TY - JOUR
T1 - Central pontine myelinolysis following pediatric living donor liver transplantation
T2 - A case report and review of literature
AU - Uchida, Hajime
AU - Sakamoto, Seisuke
AU - Sasaki, Kengo
AU - Hamano, Ikumi
AU - Shigeta, Takanobu
AU - Kanazawa, Hiroyuki
AU - Fukuda, Akinari
AU - Nosaka, Shunsuke
AU - Kubota, Masaya
AU - Kasahara, Mureo
PY - 2014/6
Y1 - 2014/6
N2 - CPM is one of the most serious neurological complications that can occur after OLT and is characterized by symmetrical demyelinization in the basis pontis. The etiology of CPM remains unclear, although the rapid correction of the serum sodium and CNI concentrations may be associated with the development of CPM. With recent advances in MRI technology, early diagnosis of CPM has become possible. Here, we present the case of a five-yr-old female who developed CNI-associated CPM after undergoing LDLT. A decreased level of consciousness and dysphasia was noted one wk after LDLT, and MRI revealed findings compatible with a diagnosis of CPM. The patient fully recovered from the neurological deficits related to CPM following the switch from the CNI to sirolimus. We propose MRI to be promptly considered for patients with abnormal neurological findings, together with the substitution of CNI with an mTOR inhibitor as a management regimen for CNI-related CPM.
AB - CPM is one of the most serious neurological complications that can occur after OLT and is characterized by symmetrical demyelinization in the basis pontis. The etiology of CPM remains unclear, although the rapid correction of the serum sodium and CNI concentrations may be associated with the development of CPM. With recent advances in MRI technology, early diagnosis of CPM has become possible. Here, we present the case of a five-yr-old female who developed CNI-associated CPM after undergoing LDLT. A decreased level of consciousness and dysphasia was noted one wk after LDLT, and MRI revealed findings compatible with a diagnosis of CPM. The patient fully recovered from the neurological deficits related to CPM following the switch from the CNI to sirolimus. We propose MRI to be promptly considered for patients with abnormal neurological findings, together with the substitution of CNI with an mTOR inhibitor as a management regimen for CNI-related CPM.
KW - calcineurin inhibitors
KW - living donor liver transplantation
KW - neurological complications
KW - pediatric liver transplantation
KW - sirolimus
UR - http://www.scopus.com/inward/record.url?scp=84900010461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900010461&partnerID=8YFLogxK
U2 - 10.1111/petr.12255
DO - 10.1111/petr.12255
M3 - Review article
C2 - 24725019
AN - SCOPUS:84900010461
SN - 1397-3142
VL - 18
SP - E120-E123
JO - Pediatric Transplantation
JF - Pediatric Transplantation
IS - 4
ER -